跳至主要内容
临床试验/NCT04625049
NCT04625049Enrolling By Invitation不适用

Does Microglial Activation Promote Lesion Growth and Progression Among Multiple Sclerosis Patients

Turku University Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2021年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
100
试验地点
1
主要终点
Correlation of the lesion volume changes to the microglial activity at the initial positron emission tomography imaging

研究概览

简要总结

The purpose of this study is to assess whether increased microglial activation (measured using TSPO-PET) at lesion rim is associated with more rapid lesion growth during 10 year follow up.

详细描述

Objective

To evaluate individual MS lesions and their growth during a total of 10 year follow-up after initial positron emission tomography (PET) -imaging with PK11195 or TMSX radioligands.

Background: Focal inflammatory lesions in the white and grey matter of the central nervous system represent the best characterized pathological phenomena of MS disease. Some MS lesions slowly expand over time. Neuropathological studies have detected inflammatory rim formed by activated microglia cells around some MS lesions and it has been suggested that the presence of the inflammatory rim could predict lesion expansion. Our hypothesis is that the lesions with higher TSPO or TMSX radioligand binding at the initial PET scan will expand more during the total of 10-year follow up compared to those lesions with lower radioligand binding. This longitudinal follow-up study will provide a more complete picture of the association of the innate immune cell activation, lesion growth and disease progression.

Study population: The research will recruit approximately 100 MS-patients who have taken part to our previous PET-imaging MS studies in Turku PET centre. The research interventions will consist of magnetic resonance imaging (MRI) scans, blood sampling, clinical neurological evaluation and patient-reported outcome measures (filling forms).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
30 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participation to a previous PET imaging study of Airas group
  • MS diagnosis

排除标准

  • Patients with other neurodegenerative disease than MS
  • Contraindication to MR scan investigations
  • Patients with claustrophobia, or a history of moderate to severe anxiety disorder or panic attacks (which could potentially lead to preterm termination of the imaging)

结局指标

主要结局

Correlation of the lesion volume changes to the microglial activity at the initial positron emission tomography imaging

时间窗: Baseline (initial PET), 3, 5, 7 and 10 years

Correlation of the lesion volume changes in the magnetic resonance imaging to the microglial activity at the initial PET imaging

次要结局

  • magnetic resonance imaging metrics(Baseline (initial PET), 3, 5, 7 and 10 years)
  • Multiple Sclerosis Composite Score(Baseline (initial positron emission tomography), 3, 5, 7 and 10 years)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验